Max Wicha


UM Startup In California Raises $82M In IPO

OncoMed Pharmaceuticals, a California-based company started at the University of Michigan in 2004 with Taubman Scholar Max Wicha, M.D., as co-founder, raised $82 million in an initial public offering that ended last week.

WWJ Newsradio 950–07/28/2013

Event Notices From February 14

The latest event and meeting notices from Michigan’s technology-focused companies, institutions and groups

WWJ Newsradio 950–02/14/2013

Stopping Breast Cancer Stem Cells Key To Cure

The key to a cure for breast cancer may lie in turning off breast cancer’s stem cells, according to a discussion Wednesday at the World Stem Cell Summit in Detroit.